Who are prednisolone and mycophenolate mofetil's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): clobetasol propionate + Methotrexate, corticosteroid and azathioprine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/prednisolone-and-mycophenolate-mofetil.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

prednisolone and mycophenolate mofetil — Competitive Intelligence Brief

prednisolone and mycophenolate mofetil (prednisolone and mycophenolate mofetil) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid and immunosuppressant. Area: Immunology.

phase 3 Corticosteroid and immunosuppressant Immunology Small molecule Live · refreshed every 30 min

Target snapshot

prednisolone and mycophenolate mofetil (prednisolone and mycophenolate mofetil) — Hospital Authority, Hong Kong. Prednisolone is a corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines, while mycophenolate mofetil is an immunosuppressant that inhibits the proliferation of T and B lymphocytes.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
prednisolone and mycophenolate mofetil TARGET	prednisolone and mycophenolate mofetil	Hospital Authority, Hong Kong	phase 3	Corticosteroid and immunosuppressant
clobetasol propionate + Methotrexate	clobetasol propionate + Methotrexate	University Hospital, Montpellier	phase 3	Corticosteroid and immunosuppressant
corticosteroid and azathioprine	corticosteroid and azathioprine	Assistance Publique - Hôpitaux de Paris	phase 3	Corticosteroid and immunosuppressant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid and immunosuppressant class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Hospital Authority, Hong Kong · 1 drug in this class
University Hospital, Montpellier · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). prednisolone and mycophenolate mofetil — Competitive Intelligence Brief. https://druglandscape.com/ci/prednisolone-and-mycophenolate-mofetil. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab